Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 24, 2018

DrugPatentWatch Database Preview

Emmaus Medcl Company Profile

« Back to Dashboard

What is the competitive landscape for EMMAUS MEDCL, and what generic and branded alternatives to EMMAUS MEDCL drugs are available?

EMMAUS MEDCL has two approved drugs.

Summary for Emmaus Medcl

US Patents:	0
Tradenames:	2
Ingredients:	1
NDAs:	2

Drugs and US Patents for Emmaus Medcl

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emmaus Medcl	NUTRESTORE	l-glutamine	FOR SOLUTION;ORAL	021667-001	Jun 10, 2004		RX	Yes	Yes		➤ Try a Free Trial				➤ Try a Free Trial
Emmaus Medcl	ENDARI	l-glutamine	FOR SOLUTION;ORAL	208587-001	Jul 7, 2017		RX	Yes	No		➤ Try a Free Trial				➤ Try a Free Trial
Emmaus Medcl	ENDARI	l-glutamine	FOR SOLUTION;ORAL	208587-001	Jul 7, 2017		RX	Yes	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Emmaus Medcl

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emmaus Medcl	NUTRESTORE	l-glutamine	FOR SOLUTION;ORAL	021667-001	Jun 10, 2004	5,288,703	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Emmaus Medcl

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla

Healthtrust

US Department of Justice

Moodys

Dow

Farmers Insurance

Daiichi Sankyo

Federal Trade Commission

Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.